{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:32:56Z","timestamp":1762504376491,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ensci.2021.100374","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T07:40:59Z","timestamp":1635320459000},"page":"100374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan"],"prefix":"10.1016","volume":"25","author":[{"given":"Ryuji","family":"Kaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ensci.2021.100374_bb0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2014.12.030","article-title":"Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE)","volume":"349","author":"Jankovic","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ensci.2021.100374_bb0010","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/mds.22622","article-title":"Effect of cervical dystonia on employment: a retrospective analysis of the ability of treatment to restore premorbid employment status","volume":"24","author":"Molho","year":"2009","journal-title":"Mov. Disord."},{"year":"2013","series-title":"Botulinus Toxin Therapy [in Japanese]","author":"Japanese Society of Neurological Therapeutics","key":"10.1016\/j.ensci.2021.100374_bb0015"},{"year":"2018","series-title":"Practical Guideline for Dystonia 2018 [in Japanese]","author":"Japanese Society of Neurology","key":"10.1016\/j.ensci.2021.100374_bb0020"},{"key":"10.1016\/j.ensci.2021.100374_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ensci.2021.100374_bb0030","first-page":"CD003633","article-title":"Botulinum toxin type A therapy for cervical dystonia","volume":"12","author":"Castel\u00e3o","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ensci.2021.100374_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fneur.2017.00035","article-title":"Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin","volume":"8","author":"Contarino","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ensci.2021.100374_bb0040","first-page":"CD004314","article-title":"Botulinum toxin type A versus botulinum toxin type B for cervical dystonia","volume":"10","author":"Duarte","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ensci.2021.100374_bb0045","first-page":"CD004315","article-title":"Botulinum toxin type B for cervical dystonia","volume":"5","author":"Marques","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ensci.2021.100374_bb0050","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: otulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the guideline development Subcommittee of the American Academy of neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.ensci.2021.100374_bb0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","article-title":"Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia","volume":"65","author":"Comella","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.ensci.2021.100374_bb0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.21724","article-title":"Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: randomized, double-blind, noninferiority trial","volume":"23","author":"Pappert","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2021.100374_bb0065","unstructured":"E.S. Consky, A. Basinski, L. Belle, R. Ranawaya, A.E. Lang, The Toronto Western spasmodic torticollis rating scale (TWSTRS): assessment of validity and inter-rater reliability, Neurology. 40 (1990) 445."},{"key":"10.1016\/j.ensci.2021.100374_bb0070","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia","volume":"53","author":"Brin","year":"1999","journal-title":"Neurology."},{"key":"10.1016\/j.ensci.2021.100374_bb0075","first-page":"203","article-title":"A double-blind comparative study to evaluate the efficacy and safety of NerBloc\u00ae (rimabotulinumtoxinB) administered in a single dose to patients with cervical dystonia","volume":"65","author":"Kaji","year":"2013","journal-title":"Brain Nerve."},{"key":"10.1016\/j.ensci.2021.100374_bb0080","unstructured":"Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, 2015 (Law No. 145 of 10 August, 1960), Final Revision: Law No. 50 of 26 June, 2015 [in Japanese]."},{"key":"10.1016\/j.ensci.2021.100374_bb0085","first-page":"65","article-title":"Inter-rater reliability while using the Toronto Western spasmodic torticollis rating scale (TWSTRS) in patients with cervical dystonia","volume":"61","author":"Kaji","year":"2009","journal-title":"Brain Nerve."},{"key":"10.1016\/j.ensci.2021.100374_bb0090","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.49.3.701","article-title":"Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia","volume":"49","author":"Lew","year":"1997","journal-title":"Neurology."},{"key":"10.1016\/j.ensci.2021.100374_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN\u00ae, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia","volume":"308","author":"Comella","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ensci.2021.100374_bb0100","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mds.26760","article-title":"Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: a randomized-controlled trial","volume":"31","author":"Poewe","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2021.100374_bb0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.parkreldis.2010.03.002","article-title":"Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia","volume":"16","author":"Truong","year":"2010","journal-title":"Parkinsonism Relat Discord."},{"key":"10.1016\/j.ensci.2021.100374_bb0110","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00415-005-0774-3","article-title":"Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure","volume":"252","author":"Dressler","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.ensci.2021.100374_bb0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/TCRM.S99239","article-title":"Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?","volume":"12","author":"Fraint","year":"2016","journal-title":"Ther. Clin. Risk Man."},{"key":"10.1016\/j.ensci.2021.100374_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/WNF.0b013e318263163c","article-title":"Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials","volume":"35","author":"Chinnapongse","year":"2012","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ensci.2021.100374_bb0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/toxins11090491","article-title":"Immunogenicity associated with botulinum toxin treatment","volume":"11","author":"Bellows","year":"2019","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.ensci.2021.100374_bb0130","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia","volume":"53","author":"Brashear","year":"1999","journal-title":"Neurology."},{"key":"10.1016\/j.ensci.2021.100374_bb0135","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/mds.20531","article-title":"Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia","volume":"20","author":"Factor","year":"2005","journal-title":"Mov. Disord."}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650221000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650221000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:18:56Z","timestamp":1762503536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650221000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"alternative-id":["S2405650221000678"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2021.100374","relation":{},"ISSN":["2405-6502"],"issn-type":[{"type":"print","value":"2405-6502"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2021.100374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100374"}}